2022
DOI: 10.3390/antiox11050867
|View full text |Cite
|
Sign up to set email alerts
|

Administration of Glutaredoxin-1 Attenuates Liver Fibrosis Caused by Aging and Non-Alcoholic Steatohepatitis

Abstract: Liver fibrosis is a sign of non-alcoholic fatty liver disease progression towards steatohepatitis (NASH) and cirrhosis and is accelerated by aging. Glutaredoxin-1 (Glrx) controls redox signaling by reversing protein S-glutathionylation, induced by oxidative stress, and its deletion causes fatty liver in mice. Although Glrx regulates various pathways, including metabolism and apoptosis, the impact of Glrx on liver fibrosis has not been studied. Therefore, we evaluated the role of Glrx in liver fibrosis induced … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 54 publications
0
5
0
Order By: Relevance
“…This suggests that neonatal proteins are more susceptible to protein oxidation, which makes early life oxidative stress a very important programming factor. We have already demonstrated the effects of early life oxidative stress over the development of neonatal diseases [1,4,7,21,26,44,45], while several adult diseases are also associated with protein oxidation [38,39,[46][47][48][49]. At 12 weeks of age, many of the variables that were decreased early in life were increased in similar proportions at 12 weeks, as a rebound effect.…”
Section: Discussionmentioning
confidence: 94%
“…This suggests that neonatal proteins are more susceptible to protein oxidation, which makes early life oxidative stress a very important programming factor. We have already demonstrated the effects of early life oxidative stress over the development of neonatal diseases [1,4,7,21,26,44,45], while several adult diseases are also associated with protein oxidation [38,39,[46][47][48][49]. At 12 weeks of age, many of the variables that were decreased early in life were increased in similar proportions at 12 weeks, as a rebound effect.…”
Section: Discussionmentioning
confidence: 94%
“…Intriguingly, the MR target gene ZBTB16 was found to be the strongest downregulated DEG in aged fibroblasts by macrophage MR deficiency. ZBTB16, a transcription factor and epigenetic regulator involved in protein–protein interactions, cell proliferation, and differentiation, has been associated with oxidative stress, metabolic syndrome, and fibrosis [ 54 , 60 ]. Regulation of ZBTB16 expression is complex and can be modulated by several signaling pathways involved in cellular stress responses, including oxidative stress and inflammation [ 54 ].…”
Section: Discussionmentioning
confidence: 99%
“…Two of the articles [ 73 , 74 ] feature the specific roles of Grx1 in liver fibrosis and lung fibrosis. Importantly, the data presented in these papers suggest a potential therapeutic role for Grx1 as an anti-fibrotic agent.…”
Section: Highlights Of the Special Issue On Glutathione And Glutaredoxinmentioning
confidence: 99%
“…Importantly, the data presented in these papers suggest a potential therapeutic role for Grx1 as an anti-fibrotic agent. Thus, Reiko Matsui and her coworkers [ 73 ] showed that the overexpression of Grx1 inhibits age-induced hepatic apoptosis and liver fibrosis in mice. On the other hand, high-fat and high-fructose diet-induced non-alcoholic steatohepatitis (NASH) leads to the downregulation of Grx1 and higher levels of S-glutathionylated proteins in the liver; overexpression of Grx-1 significantly decreases the expression of Zbtb16 and leads to the reversal of NASH progression by attenuating inflammatory and fibrotic processes.…”
Section: Highlights Of the Special Issue On Glutathione And Glutaredoxinmentioning
confidence: 99%
See 1 more Smart Citation